Parcourir par auteur "Moreau, Philippe"
Résultats 1-13 de 13
-
Bortezomib, melphalan, and dexamethasone for light-chain amyloidosis
Kastritis, Efstathios; Leleu, Xavier; Arnulf, Bertrand; et al.Journal of clinical oncology . official journal of the American Society of Clinical Oncology, 30-07-2020, JCO2001285Article dans une revue scientifique -
Carfilzomib weekly plus melphalan and prednisone in newly diagnosed transplant-ineligible multiple myeloma (ifm 2012-03)
Leleu, Xavier; Fouquet, Guillemette; Richez, Valentine; et al.Clinical Cancer Research, American Association for Cancer Research, 03-05-2019, 25 (14), 4224–4230Article dans une revue scientifique -
Compatibility at amino acid position 98 of micb reduces the incidence of graft-versus-host disease in conjunction with the cmv status
Carapito, Raphael; Aouadi, Ismail; Pichot, Angelique; et al.Bone Marrow Transplantation, 07-2020, 55, 1367–1378Article dans une revue scientifiquetexte intégral -
Daratumumab plus lenalidomide and dexamethasone for untreated myeloma
Facon, Thierry; Kumar, Shaji; Plesner, Torben; et al.The New England journal of medicine, 30-05-2019, 380, 2104-2115Article dans une revue scientifique -
Heavy plus light chain analysis to assign myeloma response is analogous to the imwg response criteria
Fouquet, Guillemette; Snell, Kym I. E.; Guidez, Stephanie; et al.Leukemia & lymphoma, 01-01-2018, 59, 583-589Article dans une revue scientifique -
Idecabtagene vicleucel in relapsed and refractory multiple myeloma
Munshi, Nikhil C.; Anderson, Larry D.; Shah, Nina; et al.The New England journal of medicine, 25-02-2021, 384, 705-716Article dans une revue scientifique -
Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD
Carapito, Raphael; Jung, Nicolas; Kwemou, Marius; et al.Blood, 13-10-2016, 128, 1979-1986Article dans une revue scientifique -
Prospective phase ii study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
Guillaume, Thierry; Malard, Florent; Magro, Leonardo; et al.Bone Marrow Transplantation, 11-2019, 54, 1815–1826Article dans une revue scientifique -
Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study
Malard, Florent; Labopin, Myriam; Yakoub-Agha, Ibrahim; et al.Blood, 16-11-2017, 130, 2186-2195Article dans une revue scientifique -
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia
Mohty, Mohamad; Malard, Florent; Blaise, Didier; et al.Haematologica, 01-01-2017, 102, 184-191Article dans une revue scientifique -
Severe chronic primary neutropenia in adults: report on a series of 108 patients
Sicre De Fontbrune, Flore; Moignet, Aline; Beaupain, Blandine; et al.Blood, 01-10-2015, 126, 1643-1650Article dans une revue scientifique -
Severe chronic primary neutropenia in adults: report on a series of 108 patients
Sicre De Fontbrune, Flore; Moignet, Aline; Beaupain, Blandine; et al.Blood, 01-10-2015, 126, 1643-1650Article dans une revue scientifique -
Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group
Frenzel, Laurent; Decaux, Olivier; Macro, Margaret; et al.Thrombosis Research, Elsevier, 01-2024, 233, 153-164Compte-rendu et recension critique d'ouvrage